These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1577978)

  • 1. AUA1: new immunocytochemical marker for detecting epithelial cells in body cavity fluids.
    Kocjan G; Sweeney E; Miller KD; Bobrow L
    J Clin Pathol; 1992 Apr; 45(4):358-9. PubMed ID: 1577978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT1 antibody staining in thin-layer specimens of benign and malignant body cavity effusions.
    Mensch LS; Weller L; Simmons-Arnold L; Gibson PC; Leiman G; Beatty B
    Acta Cytol; 2002; 46(5):813-8. PubMed ID: 12365212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytological analysis of the Tn associated antigen 83D4 in serous effusions from patients with cancer: comparison with Tn soluble glycoprotein.
    Beuzelin-Yvraut M; Bourguignat A; Phillips E; Roseto A; Osinaga E
    J Clin Pathol; 1995 May; 48(5):433-7. PubMed ID: 7629290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of monoclonal antibodies AUA1 and BER EP4 with anti-CEA for detecting carcinoma cells in serous effusions and distinguishing them from mesothelial cells.
    Robinson RJ; Royston D
    Cytopathology; 1993; 4(5):267-71. PubMed ID: 8274664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of immunoperoxidase staining in serous effusions.
    Sarker AB; Hoshida Y; Nose S
    Bangladesh Med Res Counc Bull; 1993 Aug; 19(2):33-8. PubMed ID: 8161332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical and immunocytochemical study of bladder carcinomas using the epithelium-specific, tumour-associated monoclonal antibodies HMFG1 and AUA1.
    Anagnostaki E; Skarlos D; Tamvakis N; Psaropoulou P; Blana E; Bamias A; Legaki S; Aravantinos G; Deliveliotis C; Dimopoulos K
    Br J Cancer Suppl; 1990 Jul; 10():52-6. PubMed ID: 2200496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of sialosyl-Tn in discriminating carcinomatous cells from benign mesothelium in body cavity effusions.
    Zimmerman RL; Fogt F; Bibbo M
    Acta Cytol; 1999; 43(6):1079-84. PubMed ID: 10578981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical detection of XIAP in body cavity effusions and washes.
    Wu M; Yuan S; Szporn AH; Gan L; Shtilbans V; Burstein DE
    Mod Pathol; 2005 Dec; 18(12):1618-22. PubMed ID: 16118627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of two epithelium-specific monoclonal antibodies for diagnosis of malignancy in serous effusions.
    Epenetos AA; Canti G; Taylor-Papadimitriou J; Curling M; Bodmer WF
    Lancet; 1982 Nov; 2(8306):1004-6. PubMed ID: 6127499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic characteristics of the CA-50 and CA 72-4 tumor markers in body fluids. Use in the diagnosis of malignant effusions].
    Lemberger J; Libman E; Lászlo-Klein M; Skenderović S; Novak A
    Med Pregl; 1991; 44(3-4):126-9. PubMed ID: 1921859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of the immunocytochemical study of body fluids.
    Li CY; Ziesmer SC; Wong YC; Yam LT
    Acta Cytol; 1989; 33(5):667-73. PubMed ID: 2675517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour associated antigens in diagnosis of serous effusions.
    Mezger J; Permanetter W; Gerbes AL; Wilmanns W; Lamerz R
    J Clin Pathol; 1988 Jun; 41(6):633-43. PubMed ID: 2454957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions.
    Johnston WW; Szpak CA; Lottich SC; Thor A; Schlom J
    Cancer Res; 1985 Apr; 45(4):1894-900. PubMed ID: 3884146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease.
    Ghosh AK; Mason DY; Spriggs AI
    J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical reaction of Ca1 and HMFG2 monoclonal antibodies with cells from serous effusions.
    Singer S; Boddington MM; Hudson EA
    J Clin Pathol; 1985 Feb; 38(2):180-4. PubMed ID: 3881482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of BCA-225 in the cytologic diagnosis of malignant effusions: an immunocytochemical study of 197 cases.
    Loy TS; Diaz-Arias AA; Bickel JT
    Mod Pathol; 1990 May; 3(3):294-7. PubMed ID: 2194212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homocysteine: new tumor marker in pleural fluid.
    Santotoribio JD; Cañavate-Solano C; Garcia-de la Torre A; Del Valle-Vazquez L; Arce-Matute F; Cuadros-Muñoz JF; Sanchez del Pino MJ; Bandez-Ruiz MJ; Piñuela-Rojas C; Perez-Ramos S
    Tumour Biol; 2015 Sep; 36(10):7941-5. PubMed ID: 25956279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.